Blocks viral replication

Blocks viral replication COVID-19 patients on the antiviral remdesivir recovered about 30 percent faster than those on a placebo, the results of a major clinical trial showed Wednesday, as a top US scientist hailed the drug’s “clear-cut” benefit. Although not yet considered an outright cure, it represents the first time any medication has been shown […]

continue reading